[Endovascular treatment of descending thoracic aorta XXXX ].

@entity1 @entity451 @entity1070 @entity397 @entity439 @entity731 @entity3127 @entity204 @entity1756
BACKGROUND: The natural history of @entity439 ends in @entity397 and @entity204 . In 1990 the first endovascular exclusion of an @entity439 , using an endoluminal graft implanted through the femoral arteries was performed. More recently, the same procedure has been used for @entity439 of the thoracic aorta. AIM: To report our experience with endovascular treatment of thoracic aorta @entity439 . MATERIAL AND METHODS: Analysis of 14 @entity1 (nine male), aged 30 to 79 years, treated between May 2001 and August 2002. RESULTS: The mean diameter of the @entity439 was 6.9 cm. The etiology was @entity731 in nine @entity1 . The Excluder device (Gore) was preferentially used. There was no operative mortality or @entity451 . One @entity1 had a transient leg monoparesis that reverted completely. No @entity1 had type I endoleaks. Two @entity1 had @entity1070 on discharge, that sealed spontaneously. In a follow up, ranging from 2 to 17 months, one @entity1 died of a @entity3127 and no @entity1756 has been detected. CONCLUSIONS: The short term results of endoluminal treatment of thoracic aorta @entity439 are excellent. This treatment is less invasive and has less complications than conventional surgery.
